Leuven, Vlaams-Brabant, Belgium Quest for Growth appeared to be the VC, which was created in 1999. The leading representative office of defined VC is situated in the Leuven. The venture was found in Europe in Belgium.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Quest for Growth, startups are often financed by BioMedPartners, Crescendo Ventures, VI Partners AG. The meaningful sponsors for the fund in investment in the same round are Capricorn Venture Partners, Gimv, Life Sciences Partners. In the next rounds fund is usually obtained by RUSNANO, Gimv, Kreos Capital.
Opposing the other organizations, this Quest for Growth works on 21 percentage points more the average amount of lead investments. The high activity for fund was in 2007. The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 10 - 50 millions dollars are the general things for fund. The higher amount of exits for fund were in 2015.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - Belgium. Among the most popular portfolio startups of the fund, we may highlight Plastic Logic Germany, Kiadis Pharma, Miracor Medical. Among the most popular fund investment industries, there are Medical Device, Finance. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
The overall number of key employees were 1.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Confo Therapeutics | $70M | 26 Jul 2024 | City of Brussels, Belgium | ||
Finquest | $5M | 04 Jul 2022 | Singapore, Central Region, Singapore | ||
Qpinch | $16M | 09 Sep 2021 | Antwerpen, Antwerp, Belgium | ||
EclecticIQ | $23M | 01 Dec 2020 | Amsterdam, North Holland, Netherlands | ||
EclecticIQ | $23M | 22 Sep 2020 | Amsterdam, North Holland, Netherlands | ||
HalioDx | $21M | 17 Jan 2018 | Marseille, Provence-Alpes-Côte d'Azur, France | ||
Sensolus | $3M | 12 Oct 2017 | East Flanders | ||
Sequana Medical | $9M | 23 Oct 2015 | Zurich, Zurich, Switzerland | ||
Prosonix | $23M | 24 May 2012 | England |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Confo Therapeutics | $70M | 26 Jul 2024 | City of Brussels, Belgium | ||
Finquest | $5M | 04 Jul 2022 | Singapore, Central Region, Singapore | ||
Qpinch | $16M | 09 Sep 2021 | Antwerpen, Antwerp, Belgium | ||
EclecticIQ | $23M | 01 Dec 2020 | Amsterdam, North Holland, Netherlands | ||
EclecticIQ | $23M | 22 Sep 2020 | Amsterdam, North Holland, Netherlands | ||
HalioDx | $21M | 17 Jan 2018 | Marseille, Provence-Alpes-Côte d'Azur, France | ||
Sensolus | $3M | 12 Oct 2017 | East Flanders | ||
Sequana Medical | $9M | 23 Oct 2015 | Zurich, Zurich, Switzerland | ||
Prosonix | $23M | 24 May 2012 | England |
